Evidence map›Paper›PMID 42589421›Full record

ArticleInternational journal of molecular sciences2026

IgE Occupancy and Antigen Valency Cooperate to Control FcεRI Aggregation Geometry and Signaling Efficiency.

Birgit Linhart, Rachel M Grattan, Jon Christian David, Elton D Jhamba, Christian Lupinek, Margarete Focke-Tejkl, Michael L Paffett, Shayna R Lucero, Rudolf Valenta, Lydia Tapia and 3 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Birgit LinhartDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Rachel M GrattanDepartment of Pathology, University of New Mexico, Albuquerque, NM 87131, USA.ORCID 0000-0003-1204-6615
Jon Christian DavidDepartment of Computer Science, University of New Mexico, Albuquerque, NM 87131, USA.ORCID 0000-0001-6483-5021
Elton D JhambaDepartment of Pathology, University of New Mexico, Albuquerque, NM 87131, USA.
Christian LupinekDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Margarete Focke-TejklCenter for Molecular Allergology, Karl Landsteiner University of Health Sciences, 3500 Krems, Austria.ORCID 0000-0003-3433-5071
Michael L PaffettComprehensive Cancer Center, University of New Mexico, Albuquerque, NM 87131, USA.
Shayna R LuceroDepartment of Pathology, University of New Mexico, Albuquerque, NM 87131, USA.
Rudolf ValentaDepartment of Pathophysiology and Allergy Research, Center for Pathophysiology, Infectiology, and Immunology, Medical University of Vienna, 1090 Vienna, Austria.
Lydia TapiaDepartment of Computer Science, University of New Mexico, Albuquerque, NM 87131, USA.ORCID 0000-0002-7822-7091
Bruna JacobsonDepartment of Computer Science, University of New Mexico, Albuquerque, NM 87131, USA.ORCID 0000-0001-7718-9794
Bridget S WilsonDepartment of Pathology, University of New Mexico, Albuquerque, NM 87131, USA.
Diane S LidkeDepartment of Pathology, University of New Mexico, Albuquerque, NM 87131, USA.

Funding

WOMEN'S CANCERS RESEARCH PROGRAMP30CA118100 · NCI · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Yolanda Sanchez · 2005 to 2026
$57.1M
UNM TRAININGP50GM085273 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI LIDKE, KEITH A · 2009 to 2018
$26.1M
FAIR Data Competency and Machine Learning Readiness for Biomedical ScientistsK12GM088021 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI REBECCA S. HARTLEY, Diane Lidke · 2009 to 2026
$16.4M
Imaging the Early Events in Membrane Receptor SignalingR35GM126934 · NIGMS · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Diane Lidke · 2018 to 2026
$3.1M
Government of Lower Austria; Danube Allergy Research Cluster program (DARC)NCI NIH HHS P30 CA118100NIGMS NIH HHS K12 GM088021NIGMS NIH HHS P50 GM085273NIGMS NIH HHS R35 GM126934NIH HHS 1K12GM088021-21A1NIH HHS 1P50GM085273-10NIH HHS 1R35GM126934-01A1U.S. National Science Foundation IIS-1553266
6 · The paper itself

Abstract

The crosslinking of IgE-bound FcεRI by multivalent allergens initiates mast cell and basophil signaling underlying Type 1 allergy. Yet, how allergen properties and IgE occupancy impact receptor aggregation and downstream signaling remains unclear. We used Phl p 1-specific IgE and recombinant fusion proteins presenting a Phl p 1-derived peptide in defined valencies and positions (MB1N, MB1N1C, MB2N, and MB4N) to probe antigen-dependent signaling. Tetravalent MB4N evoked stronger degranulation and Ca2+ response than bivalent antigens MB1N1C and MB2N. MB4N was also capable of signaling at low IgE occupancy and in Lyn-deficient cells. Monte Carlo simulations predicted that MB4N forms larger, complex receptor aggregates, while MB1N1C and MB2N produce linear chains. Consistently, the addition of MB4N showed larger aggregates by electron microscopy and slower mobility by single-particle tracking, compared to bivalent antigens. Thus, allergen valency and epitope spatial arrangement dictate FcεRI aggregate organization and subsequent effector cell activation.

Indexed as

AntigensImmunoglobulin EReceptors, IgESignal TransductionAllergensAnimalsCell DegranulationHumansMast CellsReceptor AggregationAllergensAntigensImmunoglobulin EReceptors, IgEallergyantigenFcεRIIgE receptormast cells

Identifiers

PMID42589421
PMCPMC13466504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.